Cargando…

Strategies for Dodging the Obstacles in CAR T Cell Therapy

Chimeric antigen receptor (CAR) T cell therapy has offered cancer patients a new alternative therapeutic choice in recent years. This novel type of therapy holds tremendous promise for the treatment of various hematologic malignancies including B-cell acute lymphoblastic leukemia (B-ALL) and lymphom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safarzadeh Kozani, Pooria, Safarzadeh Kozani, Pouya, Rahbarizadeh, Fatemeh, Khoshtinat Nikkhoi, Shahryar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047470/ https://www.ncbi.nlm.nih.gov/pubmed/33869011 http://dx.doi.org/10.3389/fonc.2021.627549

Ejemplares similares

Novel antigens of CAR T cell therapy: New roads; old destination
por: Safarzadeh Kozani, Pooria, et al.
Publicado: (2021)

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2021)

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2021)

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia
por: Hashem Boroojerdi, Mohadese, et al.
Publicado: (2020)

Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
por: Nasiri, Fatemeh, et al.
Publicado: (2023)

AS1411-functionalized delivery nanosystems for targeted cancer therapy
por: Kozani, Pooria Safarzadeh, et al.
Publicado: (2021)

Nanobody-based CAR-T cells for cancer immunotherapy
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022)

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
por: Nasiri, Fatemeh, et al.
Publicado: (2022)

Marine Bacteria versus Microalgae: Who Is the Best for Biotechnological Production of Bioactive Compounds with Antioxidant Properties and Other Biological Applications?
por: Hamidi, Masoud, et al.
Publicado: (2019)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
por: Dabiri, Hamed, et al.
Publicado: (2023)

The Evaluation and Comparison of Transcriptionally Targeted Noxa and Puma Killer Genes to Initiate Apoptosis Under Cancer-Specific Promoter CXCR1 in Hepatocarcinoma Gene Therapy
por: Khoshtinat Nikkhoi, Shahryar, et al.
Publicado: (2016)

The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues
por: Burns, Ian, et al.
Publicado: (2022)

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy
por: Nikkhoi, Shahryar Khoshtinat, et al.
Publicado: (2023)

How kinases dodge trouble
por: Leslie, Mitch
Publicado: (2007)

Dr. Amos P. Dodge
Publicado: (1916)

From J. Smith Dodge
por: Dodge, J. Smith
Publicado: (1884)

Synergistic Effect of Expressed miR-128 and Puma Protein on Targeted Induction of Tumor Cell Apoptosis
por: Khoshtinat Nikkhoi, Shahryar, et al.
Publicado: (2016)

New cell sources for CAR-based immunotherapy
por: Mazinani, Marzieh, et al.
Publicado: (2023)

CAR-T cell potency: from structural elements to vector backbone components
por: Mazinani, Marzieh, et al.
Publicado: (2022)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Optimizing methods and dodging pitfalls in microbiome research
por: Kim, Dorothy, et al.
Publicado: (2017)

Bacterial Flagella: Twist and Stick, or Dodge across the Kingdoms
por: Rossez, Yannick, et al.
Publicado: (2015)

Dodging the bullet: therapeutic resistance mechanisms in pediatric cancers
por: Shah, Nilay
Publicado: (2019)

Dodging Pitfalls in Trichoscopy: How to Nail the Right Diagnosis
por: Barreto, Taynara de Matos, et al.
Publicado: (2020)

How bacteria hack the matrix and dodge the bullets of immunity
por: Paulsson, Magnus, et al.
Publicado: (2018)

Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke
por: Parvez, Suhel, et al.
Publicado: (2022)

The great escape: A tale of the visiting professor’s Artful Dodge
por: Davis, John W.
Publicado: (2021)

Salmonella enterica Serovar Typhimurium Slows Down to Dodge Antibiotics
por: Sedwick, Caitlin
Publicado: (2014)

Dodging two bullets with one dsRNA-binding protein
por: Elbarbary, Reyad A, et al.
Publicado: (2014)

Grand Challenge: How Do We Dodge the Obesity Armageddon?
por: Samaras, Katherine
Publicado: (2016)

Pollination crisis Down‐Under: Has Australasia dodged the bullet?
por: Pyke, Graham H., et al.
Publicado: (2023)

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
por: Xin, Tianqing, et al.
Publicado: (2022)

LDHA: The Obstacle to T cell responses against tumor
por: Tang, Yu, et al.
Publicado: (2022)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

CAR T Cell Therapy for Pediatric Brain Tumors
por: Patterson, John D., et al.
Publicado: (2020)

Do plants drive translation reinitiation to dodge nonsense-mediated decay?
por: Dong, Yihan, et al.
Publicado: (2022)

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
por: Patel, Shabnum, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9h4afugjdgdt96q4mcj3ha9s9a